NASDAQ: CSCI
Cosciens Biopharma Inc Stock Ownership - Who owns Cosciens Biopharma?

Insider buying vs selling

Have Cosciens Biopharma Inc insiders been buying or selling?

No trades
There has been no insiders buying vs selling in the past 12 months.

Be the first to know when CSCI insiders and whales buy or sell their stock.

CSCI Shareholders

What type of owners hold Cosciens Biopharma Inc stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Susquehanna International Group LLP0.38%11,907$40.60kInstitution
Royal Bank Of Canada0.12%3,867$13.19kInstitution
Td Waterhouse Canada Inc0.12%3,717$12.67kInstitution
Federation Des Caisses Desjardins Du Quebec0.09%2,812$9.59kInstitution
Ubs Group Ag0.07%2,337$7.97kInstitution
National Bank Of Canada0.04%1,122$3.83kInstitution
Morgan Stanley0.02%502$1.71kInstitution
Mai Capital Management0.01%401$1.37kInstitution
Sbi Securities Co Ltd0.01%165$562.65Institution
Bnp Paribas Financial Markets0.00%100$341.00Institution

1 of 2

CSCI vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
CSCI0.86%0.00%
PTHS9.60%90.40%Net BuyingNet Buying
CYCN11.60%88.40%Net Selling
TAOX3.75%11.31%Net SellingNet Selling
XFOR93.26%6.74%Net SellingNet Buying

Cosciens Biopharma Stock Ownership FAQ

Who owns Cosciens Biopharma?

Cosciens Biopharma (NASDAQ: CSCI) is owned by 0.86% institutional shareholders, 0.00% Cosciens Biopharma insiders, and 99.14% retail investors. Susquehanna International Group LLP is the largest individual Cosciens Biopharma shareholder, owning 11,907.00 shares representing 0.38% of the company. Susquehanna International Group LLP's Cosciens Biopharma shares are currently valued at $40.60k.

If you're new to stock investing, here's how to buy Cosciens Biopharma stock.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.